Loading clinical trials...
Loading clinical trials...
Dose-ranging Double-blind, Placebo-controlled Efficacy Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
Age
4 - 11 years
Sex
ALL
Healthy Volunteers
No
Allergy Associates Medical Group, Inc.
San Diego, California, United States
Aeroallergy Research Labs of Savannah, Inc.
Savannah, Georgia, United States
University of Louisville
Louisville, Kentucky, United States
Northeast Medical Research Associates, Inc.
North Dartmouth, Massachusetts, United States
Mississippi Asthma and Allergy Clinic
Jackson, Mississippi, United States
North Carolina Clinical Research
Raleigh, North Carolina, United States
Allergy and Asthma Research Group
Eugene, Oregon, United States
Allergy Associates Research Center
Portland, Oregon, United States
Medical Research Network
The Woodlands, Texas, United States
Start Date
June 30, 2005
Primary Completion Date
September 30, 2005
Completion Date
September 30, 2005
Last Updated
December 8, 2021
Bronchodilator
DRUG
Lead Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
NCT07219173
NCT02327897
NCT07486401
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions